Michael Ordon




Dr. Michael Ordon is a Staff Urologist at St. Michael’s Hospital and an Associate Scientist in Li Ka Shing Knowledge Institute. Following his residency training at the University of Toronto, he completed a two-year fellowship at St. Michael’s Hospital specializing in kidney stones, minimally invasive urologic surgery and renal transplantation. During this time, he also completed a Master of Science in Clinical Epidemiology and Health Care Research through the Institute of Health Policy Management and Evaluation, at the University of Toronto. He also completed a second fellowship at the University of California Irvine focusing on image-guided ablation for small kidney tumours. His clinical practice focuses on the surgical management of complex kidney stones, renal transplantation, laparoscopic urology, and robotic-assisted surgery, as well as image guided cryoablation of small renal tumours. His primary research interest is in health services research and he holds an appointment as an Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES). In particular, his research focuses on the epidemiology and treatment of kidney stone disease and outcomes research for renal transplantation.

Recent Publications

  1. Lee, JY, Andonian, S, Bhojani, N, Bjazevic, J, Chew, BH, De, S et al.. Canadian Urological Association guideline: Management of ureteral calculi - Abridged version. Can Urol Assoc J. 2021;15 (12):383-393. doi: 10.5489/cuaj.7652. PubMed PMID:34847343 PubMed Central PMC8631858.
  2. Moore, J, Whalen, S, Rowe, N, Lee, J, Ordon, M, Lantz-Powers, A et al.. A high-fidelity, virtual reality, transurethral resection of bladder tumor simulator: Validation as a tool for training. Can Urol Assoc J. 2021; :. doi: 10.5489/cuaj.7285. PubMed PMID:34812720 .
  3. Lee, JY, Andonian, S, Bhojani, N, Bjazevic, J, Chew, BH, De, S et al.. Canadian Urological Association guideline: Management of ureteral calculi - Full-text. Can Urol Assoc J. 2021;15 (12):E676-E690. doi: 10.5489/cuaj.7581. PubMed PMID:34464257 PubMed Central PMC8631842.
  4. Moryousef, J, Kwong, J, Kishibe, T, Ordon, M. Systematic Review of the Prevalence of Kidney Stones in Cystic Fibrosis. J Endourol. 2021;35 (11):1693-1700. doi: 10.1089/end.2021.0151. PubMed PMID:33906435 .
  5. Thoeni, C, Ordon, M, Krizova, A, Jakate, K, Saleeb, RM. Perinephric myxoid pseudotumour of fat - first described case in allograft kidney, a mimicker of malignancy. Histopathology. 2021;79 (6):1108-1110. doi: 10.1111/his.14382. PubMed PMID:33835530 .
  6. Welk, B, Reid, J, Ordon, M, Campbell, J, Dixon, S. Do 5-alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?. Can Urol Assoc J. 2021;15 (6):214-216. doi: 10.5489/cuaj.7135. PubMed PMID:33596169 PubMed Central PMC8195573.
  7. Ordon, M, Sowerby, RJ, Ghiculete, D, Djuimo, M, Kroczak, T, Lee, JY et al.. Clips Can be Safely Used for Vascular Control of the Renal Vessels During Laparoscopic Donor Nephrectomy. Urology. 2021;147 :150-154. doi: 10.1016/j.urology.2020.10.038. PubMed PMID:33166541 .
  8. Cheung, D, Reynolds, L, Peng, M, Lee, J, Stewart, R, Pace, K et al.. Assessing the Necessity of Routine Crossmatching for Blood Transfusion in Renal Transplantation. Prog Transplant. 2020;30 (4):360-364. doi: 10.1177/1526924820958117. PubMed PMID:32964779 .
  9. Yohanna, S, Naylor, KL, McArthur, E, Lam, NN, Austin, PC, Habbous, S et al.. A Propensity Score-weighted Comparison of Outcomes Between Living and Standard Criteria Deceased Donor Kidney Transplant Recipients. Transplantation. 2020;104 (11):e317-e327. doi: 10.1097/TP.0000000000003337. PubMed PMID:32496358 .
  10. Reynolds, LF, Kroczak, T, Pace, KT, D'Arcy Honey, RJ, Ordon, M, Lee, JY et al.. Are Routine Laboratory Investigations Necessary Following Percutaneous Nephrolithotomy?. Urology. 2020;143 :80-84. doi: 10.1016/j.urology.2020.05.025. PubMed PMID:32473206 .
Search PubMed

Affiliations & Other Activities

  • Staff Urologist, Department of Medicine, St. Michael’s Hospital
  • Adjunct Scientist, Institute For Clinical Evaluative Sciences